phenobarbital will lower the level or effect of dolutegravir by raising metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration; insufficient knowledge to suggest dosage adjustment

phenobarbital will lower the extent or result of alfuzosin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.

外观 资助维基百科 创建账号 登录 个人工具 资助维基百科

phenobarbital will minimize the level or result of pirfenidone by impacting hepatic enzyme CYP1A2 metabolism. Contraindicated. Usage of robust CYP1A2 inducers should be discontinued ahead of initiating pirfenidone and prevented in the course of remedy

Forgotten password? Login Carry on browsing If you do not still have an account, remember to  make an account develop an account

phenobarbital will decrease the extent or outcome of ripretinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

phenobarbital will lessen the level or effect of propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown.

phenobarbital will reduce the extent or outcome of itraconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.

Look at cart You should Notice, shipping and delivery and tax are calculated within the checkout web page. Login to check out pricing & checkout

Phenobarbital the two decreases and stabilizes the neuron activity in your dog's Mind, that may enable lessen the quantity of seizures your pet experiences.

Phenobarbital is likewise contraindicated in sufferers with marked impairment of click here liver function, or respiratory sickness during which dyspnea or obstruction is evident. It shouldn't be administered to persons with identified past dependancy into the sedative/hypnotic team, since regular doses might be ineffectual and should lead to further more dependancy.

phenobarbital will lower the extent or effect of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Keep away from coadministration of bedaquiline with powerful CYP3A4 inducers on account of likely for decreased therapeutic influence

It is a non-sterile Resolution containing pentobarbital sodium and phenytoin sodium because the Energetic elements. Available in 100 mL a number of-dose vials, each mL consists of 390 mg pentobarbital sodium and 50 mg phenytoin sodium. Rhodamine B, a bluish-crimson fluorescent dye, is included in the formulation to aid distinguish it from parenteral drugs intended for therapeutic use.

Pharmacokinetics. Barbiturates are absorbed in various degrees pursuing oral or parenteral administration. The salts tend to be more rapidly absorbed than would be the acids. The rate of absorption is enhanced Should the sodium salt is ingested as being a dilute Remedy or taken on an empty abdomen.